Vera Therapeutics Inc

Vera Therapeutics Inc is a clinical-stage biotechnology company focused on transforming patient lives by developing therapies for immunologic diseases worldwide. As an established name in the biotechnology sector, Vera Therapeutics specialises in developing breakthrough immunotherapeutic treatments from its proprietary platform. Its standout product, atacicept, is a fusion protein undergoing testing for use in different autoimmune disease settings. Vera is also working on MAU868, a monoclonal antibody that neutralises infection by blocking BKV binding to hot cells. Stay up to date on the share price of VERA by adding it to your eToro watchlist.